Fumei Gao | toxicology | Best Researcher Award

Published on by Environmental Scientists

Dr. Fumei Gao | toxicology | Best Researcher Award

Associate Professor, Peking University Peoples’ Hospital, China.

Dr. Fumei Gao is a distinguished Deputy Chief Physician in Obstetrics and Gynecology at Peking University People’s Hospital. With profound expertise in reproductive toxicology and infertility treatment, she integrates clinical practice with molecular research to address reproductive health challenges. Her work spans environmental exposure assessment and fertility treatments, making significant contributions to both clinical and academic fields. 💡🩺

Professional Profile

Scopus

🎓 Education

Dr. Gao earned her Bachelor’s degree in Clinical Medicine from Qingdao Medical College, Qingdao University (2003.9 – 2008.7), followed by her Master’s and M.D. in Obstetrics and Gynecology from Peking University People’s Hospital (2008.9 – 2013.7). Her robust academic foundation underpins her advanced clinical and research pursuits in reproductive health. 📚🔬

đź’Ľ Experience

Dr. Gao began her career as a Postdoctoral Fellow at the College of Urban and Environmental Sciences, Peking University (2013.7 – 2015.7). She completed her Residency in Obstetrics and Gynecology at Peking University People’s Hospital (2008.9 – 2013.7 & 2015.7 – 2016.6). She then served as Attending Physician (2016.6 – 2022.8) and is currently a Deputy Chief Physician (2022.8 – present), focusing on infertility and reproductive toxicology. 👩‍⚕️

🔬 Research Interests

Her research focuses on the impact of environmental disruptor chemicals on reproductive health, reproductive toxicology mechanisms, infertility treatments, and ovarian stimulation. 💊 She is skilled in molecular biology techniques like qPCR, Western Blot, IHC, and in vivo mouse models, as well as clinical data science and statistical analysis. 🧪📊

đź“š Top Noted Publications

Exposure assessment of aryl-organophosphate esters and reproductive hormone disruption in women
đź”— Environment International, 2022
Cited by several studies for its impact on endocrine health.

Screening of Organophosphate Flame Retardants in Placental Models and Mice
đź”— Environmental Health Perspectives, 2022
Key reference for placental toxicology research.

Mono-2-ethylhexyl phthalate inhibits trophoblast invasion via PPARÎł pathway
đź”— Toxicology and Applied Pharmacology, 2017
Widely cited in reproductive toxicology research.

Phthalate Metabolites in Pregnancy and Risk of Clinical Pregnancy Loss
đź”— Environmental Science & Technology, 2015
Recognized in environmental exposure studies.

Low house cleaning frequency and miscarriage risk in China
đź”— International Journal of Environmental Research and Public Health, 2021
Highlighted in lifestyle and reproductive health studies.

Effects of letrozole co-treatment on cumulative live-birth rate in IVF
đź”— Frontiers in Medicine, 2022
Frequently referenced in assisted reproductive technology research.

Effect of Dual Trigger in IVF for Women with Diminished Ovarian Reserve
đź”— Current Medical Science, 2022
Significant for fertility treatment advancements.

Premature Luteinizing Hormone Rise and Reduced IVF Success in Older Women
đź”— Frontiers in Endocrinology, 2021
Cited for IVF cycle optimization in older patients.

Dual Trigger Using GnRH Agonist and hCG in Normal Responders in IVF
đź”— Frontiers in Medicine, 2021
Frequently referenced for improving IVF protocols.

Case Reports on Endometriosis-Related Hemoperitoneum in Pregnancy
đź”— Chinese Medical Journal, 2018
Important clinical reference for rare obstetric cases.

Conclusion

Dr. Fumei Gao is highly suitable for the Best Researcher Award given her proven research excellence, clinical expertise, and significant contributions to reproductive toxicology and infertility treatments. Her publications, covering high-impact studies on endocrine disruptors and infertility, clearly demonstrate her leadership in this niche field. With continued focus on international networking and translational research, she is poised to make even greater strides in reproductive medicine. She fully meets the merit required for this award.

Mrs. Ruwani Suraweera | Toxicology | Best Researcher Award

Published on by Environmental Scientists

Mrs. Ruwani Suraweera | Toxicology | Best Researcher Award

Doctoral student, Queensland University of Technology, Australia

🎓 Dr. Ruwani Kaushalya Suraweera is a dedicated academic and researcher specializing in formulation development, drug delivery, and pharmaceutical technology. Currently pursuing her Ph.D. at Queensland University of Technology, Australia, she has made significant contributions to pharmacy education and research in Sri Lanka. Her expertise spans clinical sciences, nanotechnology, and innovative pharmaceutical practices. A distinguished scholar and pharmacist, Dr. Suraweera is recognized for her impactful publications, awards, and professional affiliations.

Publication Profile

Google Scholar

Education

📚 Dr. Suraweera holds a Ph.D. candidacy at Queensland University of Technology, Australia (2023–present). She completed her M.Phil. in Chemical Sciences (2017–2022) with exceptional grades at the University of Peradeniya, Sri Lanka. Her undergraduate achievement, a B.Pharm (Honours) with a GPA of 3.65, earned her the distinction of being the best performer in her batch. Additionally, she has earned certifications in marketing, quality management systems, and first aid.

Experience

💼 Dr. Suraweera has a rich academic career as a Lecturer in Pharmacy at the University of Peradeniya, Sri Lanka (2014–2023), where she also served as a Temporary Lecturer earlier. Her work focuses on teaching, research, and mentoring students in advanced pharmaceutical practices. She has also contributed to academia through her roles in curriculum development and clinical training.

Research Interests

🔬 Dr. Suraweera’s research explores cutting-edge topics in pharmaceutical sciences, including formulation development, drug delivery systems, and nanotechnology applications in healthcare. She is passionate about developing innovative therapeutic solutions to improve patient outcomes.

Awards

🏆 Dr. Suraweera has received multiple prestigious grants and scholarships, such as the University Research Grant (2016) and ITEC scholarship from the Government of India. Her academic excellence has been acknowledged with university scholarships and awards for exceptional performance in pharmacy and chemistry.

Publications

Ruwani K. Suraweera, et al. (2024). Development and Characterization of Spray-Dried Combined Levofloxacin–Ambroxol Dry Powder Inhaler Formulation. Pharmaceutics, 16(12). [Cited by articles in PubMed]
Read the publication

Navanjana T.P. Uyangoda, et al. (2022). Investigation of the Use of Medicinal Plants and Natural Products for COVID-19 Prevention. Sri Lankan Journal of Health Sciences, 1(2). [Cited by articles in Scopus]

Sathya S, et al. (2017). Formulation Development of Cream Incorporating Extracts of Glycyrrhia glabara. Pharmaceutical Journal of Sri Lanka, 7(1). [Cited in local archives]

Suraweera RK, et al. (2015). Assessing the Characterizations of Ketoprofen Loaded and Unloaded Virgin Coconut Oil-based Creamy Nanoemulsion. Asian Journal of Pharmaceutical and Clinical Research, 8(1). [Cited by 15 articles]